Advanced-technique radiation therapy for nasopharyngeal carcinoma in a low resource setting: a review of treatment-related quality of life.

IMRT Nigeria advanced-technique radiation health-related quality of life nasopharyngeal carcinoma

Journal

Ecancermedicalscience
ISSN: 1754-6605
Titre abrégé: Ecancermedicalscience
Pays: England
ID NLM: 101392236

Informations de publication

Date de publication:
2024
Historique:
received: 26 02 2024
medline: 21 10 2024
pubmed: 21 10 2024
entrez: 21 10 2024
Statut: epublish

Résumé

Nasopharyngeal carcinoma (NPC) is a rare but significant public health concern, especially in Africa, with a rising global incidence. This study aimed to investigate the pattern of presentation, treatment outcomes and impact on health-related quality of life (HRQOL) of NPC patients at a tertiary institution in Lagos, Nigeria. A retrospective review of all nasopharyngeal cancer patients ( Among 125 patients, the mean age was 46.21 ± 17.82 years with 76% male. Comorbidities were reported in 34 patients (27.2%), smoking history in 18 patients (14.4%) and 50 patients (40%) reported alcohol consumption. Environmental risk factors were identified in six patients (4.8%). The most prevalent histology was squamous cell carcinoma (92.8%), and stage IV was the most common stage (42.4%). Chemoradiation was the primary treatment (63.2%), with intensity-modulated radiotherapy being the most utilised approach (51.2%). Among 125 patients, 51 completed the EORTC questionnaire. Weight loss, sticky saliva, dry mouth, difficulties in swallowing and problems with the sense of taste and smell were the most severe symptoms reported by patients. In the follow-up, 79.2% of patients were reached (50.4% alive, 28.8% deceased). Mortality was significantly associated with age >65 years, weight loss at presentation and consumption of grilled/smoked food. The study highlights key aspects of NPC in our region including the predominance in males, advanced disease stage at presentation and persistent symptoms post-treatment. Our findings point to the need for targeted initiatives to improve early detection and quality of life for nasopharyngeal patients in the country.

Sections du résumé

Background UNASSIGNED
Nasopharyngeal carcinoma (NPC) is a rare but significant public health concern, especially in Africa, with a rising global incidence. This study aimed to investigate the pattern of presentation, treatment outcomes and impact on health-related quality of life (HRQOL) of NPC patients at a tertiary institution in Lagos, Nigeria.
Methodology UNASSIGNED
A retrospective review of all nasopharyngeal cancer patients (
Results UNASSIGNED
Among 125 patients, the mean age was 46.21 ± 17.82 years with 76% male. Comorbidities were reported in 34 patients (27.2%), smoking history in 18 patients (14.4%) and 50 patients (40%) reported alcohol consumption. Environmental risk factors were identified in six patients (4.8%). The most prevalent histology was squamous cell carcinoma (92.8%), and stage IV was the most common stage (42.4%). Chemoradiation was the primary treatment (63.2%), with intensity-modulated radiotherapy being the most utilised approach (51.2%). Among 125 patients, 51 completed the EORTC questionnaire. Weight loss, sticky saliva, dry mouth, difficulties in swallowing and problems with the sense of taste and smell were the most severe symptoms reported by patients. In the follow-up, 79.2% of patients were reached (50.4% alive, 28.8% deceased). Mortality was significantly associated with age >65 years, weight loss at presentation and consumption of grilled/smoked food.
Conclusion UNASSIGNED
The study highlights key aspects of NPC in our region including the predominance in males, advanced disease stage at presentation and persistent symptoms post-treatment. Our findings point to the need for targeted initiatives to improve early detection and quality of life for nasopharyngeal patients in the country.

Identifiants

pubmed: 39430069
doi: 10.3332/ecancer.2024.1770
pii: can-18-1770
pmc: PMC11489088
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1770

Informations de copyright

© the authors; licensee ecancermedicalscience.

Déclaration de conflit d'intérêts

The authors declare that there are no conflicts of interest regarding the publication of this manuscript; and no other relationships or activities that could appear to have influenced the submitted work.

Auteurs

Godwin Uwagba (G)

NSIA -LUTH Cancer Centre, Lagos University Teaching Hospital, Lagos 100001, Nigeria.

Adedayo Joseph (A)

NSIA -LUTH Cancer Centre, Lagos University Teaching Hospital, Lagos 100001, Nigeria.
Department of Radiation Biology, Radiotherapy, and Radiodiagnosis, College of Medicine, University of Lagos, Lagos 100001, Nigeria.

Muhammed Habeebu (M)

NSIA -LUTH Cancer Centre, Lagos University Teaching Hospital, Lagos 100001, Nigeria.

Eben Aje (E)

NSIA -LUTH Cancer Centre, Lagos University Teaching Hospital, Lagos 100001, Nigeria.

Aishat Oladipo (A)

NSIA -LUTH Cancer Centre, Lagos University Teaching Hospital, Lagos 100001, Nigeria.
Research Department, NSIA-LUTH Cancer Centre, Lagos University Teaching Hospital, Lagos 100001, Nigeria.

Olufunmilayo Fagbemide (O)

NSIA -LUTH Cancer Centre, Lagos University Teaching Hospital, Lagos 100001, Nigeria.

Precious Akowe (P)

NSIA -LUTH Cancer Centre, Lagos University Teaching Hospital, Lagos 100001, Nigeria.
Research Department, NSIA-LUTH Cancer Centre, Lagos University Teaching Hospital, Lagos 100001, Nigeria.

Azeezat Ajose (A)

NSIA -LUTH Cancer Centre, Lagos University Teaching Hospital, Lagos 100001, Nigeria.
Research Department, NSIA-LUTH Cancer Centre, Lagos University Teaching Hospital, Lagos 100001, Nigeria.

Adebayo Abe (A)

NSIA -LUTH Cancer Centre, Lagos University Teaching Hospital, Lagos 100001, Nigeria.

Samuel Adeneye (S)

NSIA -LUTH Cancer Centre, Lagos University Teaching Hospital, Lagos 100001, Nigeria.
College of Medicine, University of Lagos, Lagos 100001, Nigeria.

Ibrahim Elhamamsi (I)

NSIA -LUTH Cancer Centre, Lagos University Teaching Hospital, Lagos 100001, Nigeria.

Abdallah Kotkat (A)

NSIA -LUTH Cancer Centre, Lagos University Teaching Hospital, Lagos 100001, Nigeria.

Nusirat Adedewe (N)

NSIA -LUTH Cancer Centre, Lagos University Teaching Hospital, Lagos 100001, Nigeria.

Inioluwa Ariyo (I)

NSIA -LUTH Cancer Centre, Lagos University Teaching Hospital, Lagos 100001, Nigeria.

Wonuola Adetugbogbo (W)

NSIA -LUTH Cancer Centre, Lagos University Teaching Hospital, Lagos 100001, Nigeria.

Francis Durosinmi-Etti (F)

NSIA -LUTH Cancer Centre, Lagos University Teaching Hospital, Lagos 100001, Nigeria.

Classifications MeSH